- Summits
- Sponsorship
- Retreats
- Media Opportunities
- News
- About
The rise of artificial intelligence in healthcare has opened new possibilities for patient support, but in mental health, safety and clinical oversight remain critical.
New York-based Jimini Health is stepping into this space with a model designed to keep clinicians firmly at the center of care. The company has announced a $17 million seed funding round to help behavioral health organizations deploy AI safely and effectively at scale.
At the heart of its platform is Sage, an AI-powered behavioral health assistant that supports patients before, after, and between therapy sessions. Unlike general-purpose chatbots, every interaction is supervised by a human clinical team, while all care decisions remain with licensed clinicians.
The timing of the raise is particularly notable as more patients increasingly turn to unsupervised AI chatbots for mental health support, a trend that continues to raise concerns across the sector.
“We believe that Jimini’s platform can help address both efficacy and access, by making therapists both more effective with their work and able to help more patients,” said Mark Jacobstein, President of Jimini Health. “In addition, Jimini will help with the tsunami of demand we see reflected in the inappropriate use of general-purpose chatbots for therapy.”
The funding round was backed by M13, Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind, bringing Jimini Health’s total funding to more than $25 million.
For investors, the urgency behind this space is clear.
“When 1 million people a week are discussing suicide with a product that was never designed to handle it, that’s not an edge case, it’s a systemic gap,” said Morgan Blumberg, Partner at M13. “Jimini is building the clinical infrastructure this category has never had: real supervision, real clinicians, real oversight.”
The latest investment will support team expansion, including the hiring of more forward-deployed engineers, machine learning engineers, and software engineers, alongside growth of its business development team.
Jimini Health is also looking to expand partnerships with behavioral health provider organizations across the country and extend its clinical capabilities across multiple care settings, comorbidities, and patient engagement modalities.
In a growing field of AI mental health companies, many solutions focus primarily on improving clinician workflows. Jimini’s approach, however, places emphasis on continuous patient engagement within existing clinical care models, aiming to improve both access and outcomes.
Led by experts across psychology, AI, biopharma, and healthcare, the company is positioning itself as a responsible innovator in the behavioral health space, combining evidence-based therapeutic methods with continuous AI-supported engagement.
As demand for mental health services continues to rise, Jimini Health’s latest funding round reflects growing confidence in AI solutions that extend care while preserving clinical oversight.
As conversations around AI, clinical oversight, and the future of patient care continue to define the healthcare agenda, these themes are expected to remain central at MedTech World North America 2026.
Following the success of its Middle East flagship event, MedTech World is now heading to Florida for MedTech World North America, taking place in West Palm Beach from 11 to 13 May 2026.
The North America edition will bring together global industry leaders, investors, innovators, and healthcare experts for focused discussions on AI-driven healthcare innovation, digital transformation, investment trends, and cross-border collaboration opportunities.
For organizations and leaders working at the forefront of healthcare technology, from behavioral health AI to next-generation diagnostics and therapeutics, the event extends an opportunity to connect with the ecosystem leading what comes next.
If you are looking to be part of this milestone flagship event, you can engage in ways that align with your goals:
